American Brachytherapy Society
Press Releases

GT Medical Technologies Announces the Presentation of Data Demonstrating the Safety Profile of GammaTile Therapy for Various Brain Tumors

GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced the presentation of clinical data from a prospective study of GammaTile® Therapy in patients with previously irradiated intracranial neoplasms (brain tumors) at the American Brachytherapy Society (ABS) 2019 Annual Meeting in Miami.

Implantable Brain Tumor Treatment
News Articles

Implantable Brain Tumor Treatment

GT Medical Technologies is a Tempe-based company that has created a new way to target brain tumors, like the type that took the late Senator John McCain’s life. Watch the interview with Dr. David Brachman, co-founder and Chief Technology Officer of GT Medical Technologies, to learn more